Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Zhongzhi Pharmaceutical Holdings Limited ( (HK:3737) ) is now available.
Zhongzhi Pharmaceutical Holdings Limited has issued a profit warning, anticipating a 45% decrease in net profit for the year ended December 31, 2024, compared to the previous year. This expected decline in profit is attributed to a decrease in gross profit margin due to changes in product structures and increased investment in online and offline advertising. Stakeholders are advised to exercise caution when dealing with the company’s shares, as the official financial results are expected to be announced by March 2025.
More about Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company, along with its subsidiaries, focuses on the production and sale of pharmaceutical products.
YTD Price Performance: 3.03%
Average Trading Volume: 333,086
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$863.9M
For an in-depth examination of 3737 stock, go to TipRanks’ Stock Analysis page.
